307 related articles for article (PubMed ID: 28078868)
1. Minoxidil dose response study in female pattern hair loss patients determined to be non-responders to 5% topical minoxidil.
McCoy J; Goren A; Kovacevic M; Shapiro J
J Biol Regul Homeost Agents; 2016; 30(4):1153-1155. PubMed ID: 28078868
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study.
Suchonwanit P; Iamsumang W; Rojhirunsakool S
Am J Clin Dermatol; 2019 Feb; 20(1):147-153. PubMed ID: 30206824
[TBL] [Abstract][Full Text] [Related]
3. Comparing the Efficacy of Mesotherapy to Topical Minoxidil in the Treatment of Female Pattern Hair Loss Using Ultrasound Biomicroscopy: A Randomized Controlled Trial.
Hunter N; Sayed K; Hay RA; Allam R; Hussein N
Acta Dermatovenerol Croat; 2019 Mar; 27(1):1-7. PubMed ID: 31032783
[TBL] [Abstract][Full Text] [Related]
4. The Efficacy of Topical Minoxidil for Non-Scarring Alopecia: A Systematic Review.
Sung CT; Juhasz ML; Choi FD; Mesinkovska NA
J Drugs Dermatol; 2019 Feb; 18(2):155-160. PubMed ID: 30794366
[TBL] [Abstract][Full Text] [Related]
5. 5% Minoxidil: treatment for female pattern hair loss.
Gupta AK; Foley KA
Skin Therapy Lett; 2014; 19(6):5-7. PubMed ID: 25807073
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Minoxidil 2% Solution in Combination With a Botanical Hair Solution in Women With Female Pattern Hair Loss/Androgenic Alopecia.
McMichael A; Pham H; von Grote E; Meckfessel MH
J Drugs Dermatol; 2016 Apr; 15(4):398-404. PubMed ID: 27050694
[TBL] [Abstract][Full Text] [Related]
7. Doppler laser imaging predicts response to topical minoxidil in the treatment of female pattern hair loss.
McCoy J; Kovacevic M; Situm M; Stanimirovic A; Bolanca Z; Goren A
J Biol Regul Homeost Agents; 2016; 30(1):131-4. PubMed ID: 27049083
[TBL] [Abstract][Full Text] [Related]
8. Topical minoxidil dose-response effect in alopecia areata.
Fiedler-Weiss VC; West DP; Buys CM; Rumsfield JA
Arch Dermatol; 1986 Feb; 122(2):180-2. PubMed ID: 3947124
[TBL] [Abstract][Full Text] [Related]
9. Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil in the treatment of female androgenetic alopecia.
Roberts J; Desai N; McCoy J; Goren A
Dermatol Ther; 2014; 27(4):252-4. PubMed ID: 24773771
[TBL] [Abstract][Full Text] [Related]
10. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD
J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503
[TBL] [Abstract][Full Text] [Related]
11. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women.
Blume-Peytavi U; Hillmann K; Dietz E; Canfield D; Garcia Bartels N
J Am Acad Dermatol; 2011 Dec; 65(6):1126-1134.e2. PubMed ID: 21700360
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of 5% minoxidil topical foam in male pattern hair loss treatment and patient satisfaction.
Hasanzadeh H; Nasrollahi SA; Halavati N; Saberi M; Firooz A
Acta Dermatovenerol Alp Pannonica Adriat; 2016 Sep; 25(3):41-44. PubMed ID: 27695865
[TBL] [Abstract][Full Text] [Related]
13. Topical minoxidil in male pattern baldness: effects of discontinuation of treatment.
Olsen EA; Weiner MS
J Am Acad Dermatol; 1987 Jul; 17(1):97-101. PubMed ID: 3301926
[TBL] [Abstract][Full Text] [Related]
14. Low-dose daily aspirin reduces topical minoxidil efficacy in androgenetic alopecia patients.
Goren A; Sharma A; Dhurat R; Shapiro J; Sinclair R; Situm M; Kovacevic M; Lukinovic Skudar V; Goldust M; Lotti T; McCoy J
Dermatol Ther; 2018 Nov; 31(6):e12741. PubMed ID: 30226287
[TBL] [Abstract][Full Text] [Related]
15. Low level light-minoxidil 5% combination versus either therapeutic modality alone in management of female patterned hair loss: A randomized controlled study.
Esmat SM; Hegazy RA; Gawdat HI; Abdel Hay RM; Allam RS; El Naggar R; Moneib H
Lasers Surg Med; 2017 Nov; 49(9):835-843. PubMed ID: 28489273
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study.
Tanglertsampan C
J Med Assoc Thai; 2012 Oct; 95(10):1312-6. PubMed ID: 23193746
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of androgenic alopecia with topical minoxidil].
Brenner S; Tamir A
Harefuah; 1991 Nov; 121(9):297-302. PubMed ID: 1800277
[TBL] [Abstract][Full Text] [Related]
18. A Phase III, Multicenter, Parallel-Design Clinical Trial to Compare the Efficacy and Safety of 5% Minoxidil Foam Versus Vehicle in Women With Female Pattern Hair Loss.
Bergfeld W; Washenik K; Callender V; Zhang P; Quiza C; Doshi U; Blume-Peytavi U
J Drugs Dermatol; 2016 Jul; 15(7):874-81. PubMed ID: 27391639
[TBL] [Abstract][Full Text] [Related]
19. Randomized clinical trial comparing 5% and 1% topical minoxidil for the treatment of androgenetic alopecia in Japanese men.
Tsuboi R; Arano O; Nishikawa T; Yamada H; Katsuoka K
J Dermatol; 2009 Aug; 36(8):437-46. PubMed ID: 19691748
[TBL] [Abstract][Full Text] [Related]
20. Dose-response study of topical minoxidil in male pattern alopecia.
Shupack JL; Kassimir JJ; Thirumoorthy T; Reed ML; Jondreau L
J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):673-6. PubMed ID: 3549801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
